SA
ALPMY logo
Astellas Pharma Inc.(ALPMY)
Closing price · checked 10:13 PM ETAbout this dataData status
$16.96▲0.06 (0.36%)
Extended:$16.96+0.00 (+0.00%)· 10:13 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average (VIX 24.6)

Overview →

Astellas Pharma Inc. (ALPMY)

R&D Expenses

¥24.20B

TTM · Period ending: · JPY

ALPMY logo

ALPMY R&D Expenses

Latest reported¥24.20B JPY
ALPMY R&D Expenses · JPY (¥181.96B → ¥24.20B)
High-resolution chart · PNG

What is r&d expenses?

Research and development spending.

ALPMY r&d expenses history

Annual fiscal periods · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.

Astellas Pharma Inc. R&D Expenses — Annual fiscal periods (JPY)
Period endingR&D Expenses (JPY)
333,813,538,000
327,651,000,000
294,200,000,000
276,128,000,000
246,010,000,000
224,489,000,000
224,226,000,000
208,682,000,000
220,781,000,000
208,129,000,000
225,665,000,000
206,600,000,000
191,500,000,000
181,955,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.